Integris Medtech Limited Unlisted Share Price
₹ 0 (0) (0%) 5Y
Integris Medtech Limited Unlisted Share Price
₹ 0
Integris Medtech Limited Unlisted Share Price
*Best In Industry
About Integris Medtech Limited Unlisted Share Price
Integris Medtech Limited Unlisted Share Price
Integris Medtech Limited (formerly known as Integris Health Private Limited) is a fast-growing player in India’s healthcare and medical technology sector. The company is focused on delivering innovative and high-quality medical solutions designed to make healthcare more accessible and efficient.
At Unlisted Radar, we provide investors with the latest updates, insights, and data on the Integris Medtech Limited Unlisted Share Price — helping you make informed and smarter investment decisions in the unlisted market.
About Integris Medtech Limited
Established in 2008, Integris Medtech Limited has built a strong reputation in the healthcare domain through continuous innovation and a commitment to patient-centric solutions.
The company is backed by reputable promoters — Evercure Holdings Pte. Ltd., Medicore Holdings Pte. Ltd., Gurmit Singh Chugh, and Punita Sharma — all of whom bring international expertise and strategic vision to the organization.
The company’s Corporate Identity Number (CIN) is U85110DL2008PLC177230, and it operates from:
📍 Registered Office: New Rajinder Nagar, New Delhi – 110060
🏢 Corporate Office: Noida – 201301, Uttar Pradesh
🌐 Website: www.integrismedtech.com
The company’s Group General Counsel, Company Secretary, and Compliance Officer is Mr. Darpan Batra, ensuring all investor communications and regulatory compliances are managed seamlessly.
Integris Medtech Limited Unlisted Share Price Overview
The Integris Medtech Limited Share Price is a reflection of investor sentiment toward the company’s growth trajectory, upcoming IPO, and position in the healthcare innovation ecosystem.
As an unlisted company, its shares are traded privately among investors who seek early exposure to promising businesses before their public market debut. The current trend indicates strong investor confidence in the medtech sector, driven by increasing demand for advanced healthcare solutions across India.
On Unlisted Radar, investors can monitor real-time changes in the Integris Medtech Limited Share Price, access historical pricing data, and understand valuation trends that provide a deeper view of its pre-IPO market performance.
Details of the Upcoming Integris Medtech Limited Offer
According to the company’s Draft Red Herring Prospectus (DRHP) filed in 2025, the upcoming public offering will include both a Fresh Issue and an Offer for Sale (OFS):
- Fresh Issue: Equity shares aggregating up to ₹9,250 million
- Offer for Sale: Up to 21,674,531 equity shares of face value ₹1 each
- Promoter Selling Shareholders:
- Evercure Holdings Pte. Ltd. – up to 15,174,251 shares (average acquisition cost ₹203.43 per share)
- Gurmit Singh Chugh – up to 3,250,140 shares (average acquisition cost ₹31.59 per share)
- Punita Sharma – up to 3,250,140 shares (average acquisition cost ₹31.59 per share)
- Evercure Holdings Pte. Ltd. – up to 15,174,251 shares (average acquisition cost ₹203.43 per share)
The Integris Medtech Limited shares will be listed on BSE and NSE once the IPO is completed. This listing is expected to improve liquidity and offer early investors a clear exit opportunity.
Why Are Investors Tracking Integris Medtech Limited?
India’s healthcare industry is projected to reach over $650 billion by 2025, and medical technology is a major growth driver. With its strong R&D focus, experienced promoters, and scalable operations, Integris Medtech Limited is well-positioned to capture a significant share of this expanding market.
Investors are closely watching the Integris Medtech Limited Share Price because:
- The company operates in a high-growth medtech segment.
- It has global strategic backing from experienced promoters.
- The upcoming IPO may unlock significant value appreciation.
- Its business fundamentals indicate sustainable long-term growth potential.
Investment Perspective
Investing in unlisted shares gives investors the opportunity to participate in a company’s journey before it hits the stock market. The Integris Medtech Limited unlisted shares allow early investors to benefit from the company’s expansion in India’s fast-evolving healthcare sector.
However, it’s important to remember that unlisted shares carry liquidity and market risks, as they are not traded on formal exchanges. That’s where Unlisted Radar helps — providing trusted data, verified sources, and transparent insights into pricing, valuation, and future potential.
By keeping a close eye on the Integris Medtech Limited Unlisted Share Price, investors can plan entry or exit decisions strategically and align their portfolio with upcoming healthcare opportunities.
Risk and Regulatory Overview
Like any pre-IPO investment, Integris Medtech Limited carries certain risks:
- There is no established secondary market until listing.
- Valuation may fluctuate depending on market sentiment.
- Regulatory or operational changes in the healthcare industry can affect profitability.
The company’s DRHP also highlights that the offer is made under Regulation 6(2) of the SEBI (ICDR) Regulations, 2018. This ensures compliance with Indian securities law, providing investors with a structured and transparent investment framework.
Why Choose Unlisted Radar?
At Unlisted Radar, we simplify investing in unlisted companies by offering:
- Accurate and updated unlisted share prices
- Verified company financials and background information
- Market insights and upcoming IPO details
- Easy navigation for tracking and comparing companies
Our mission is to help investors make informed, confident, and timely investment decisions in the unlisted market. Whether you’re exploring early-stage healthcare opportunities or looking to diversify your pre-IPO portfolio, Unlisted Radar is your trusted partner.
Integris Medtech Limited represents a compelling opportunity in India’s booming healthcare and medtech sector. As the company prepares for its public debut, monitoring the Integris Medtech Limited Unlisted Share Price can provide investors with early insights into valuation trends and growth potential.
Stay informed with Unlisted Radar — your reliable source for updates on unlisted shares, valuations, and IPO opportunities across India.
Read MoreFundamentals
Integris Medtech Limited Unlisted Share Price
₹ 0
Per Equity ShareLot Size
Share
52 Week High
₹ 0
52 Week Low
₹ 0
Depository
PAN Number
AABCI9779A
ISIN Number
CIN
U85110DL2008PLC177230
RTA
KFin Technologies Limited
Market Cap (in Cr.)
₹ -
P/E Ratio
-
P/B Ratio
-
Debt to Equity
-
ROE(%)
-
Book Value
-
Face Value
1.00
Total Shares
108338049
Financials
P&L Statement
| P&L Statement | 2021 | 2022 | 2023 |
|---|---|---|---|
| Interest Earned | 0.00 | 0.00 | 0.00 |
| Other Income | 107.41 | 110.92 | 354.74 |
| Interest Expended | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4461.98 | 6839.79 | 10449.82 |
| Provisions and contingencies | 0.00 | 0.00 | 0.00 |
| PAT | 333.86 | 745.26 | 1506.19 |
| EPS | 0.59 | 1.32 | 2.54 |
| Gross NPA | 0.00 | 0.00 | 0.00 |
| Net NPA | 0.00 | 0.00 | 0.00 |
| Financial Ratios | 2023 | 2024 | 2025 |
|---|---|---|---|
| Advances | 0.00 | 0.00 | 0.00 |
| Book Value | 316.09 | 313.11 | 338.66 |
| P/B | 0.00 | 0.00 | 0.00 |
| ROE(%) | 5.35 | 0.31 | 4.45 |
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 |
|---|---|---|---|
| Fixed Assets | 1143.95 | 1606.43 | 1989.13 |
| Cash and Balances | 1084.97 | 1157.20 | 1528.47 |
| Investments | 1560.39 | 2011.68 | 2717.73 |
| Advances | 0.00 | 0.00 | 0.00 |
| Other Assets | 1304.44 | 1921.64 | 2437.09 |
| Total Assets | 5093.75 | 6696.95 | 8672.42 |
| Liabilities | 2023 | 2024 | 2025 |
|---|---|---|---|
| Share Capital | 27.06 | 30.02 | 36.12 |
| FV | 10.00 | 1.00 | 1.00 |
| Reserves | 11357.12 | 11507.37 | 22998.35 |
| Borrowings | 8131.03 | 17294.58 | 7934.18 |
| Deposits | 0 | 0 | 0 |
| Other Liabilities | 3785.78 | 3882.00 | 4048.55 |
| Total Liabilities | 23310.99 | 32714.97 | 35018.2 |
Cash-Flow Statement
| Cash-Flow Statement | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| PBT | -145.43 | 256.16 | 1145.51 | 2780.00 |
| OPBWC | 1679.75 | 2023.17 | 3317.67 | 811.97 |
| Term Deposit | 480.62 | 813.67 | 2947.98 | 1313.13 |
| Change in Investment | 0.00 | 0.00 | -3196.63 | 500.97 |
| Change in Advances | 31.62 | 68.41 | 26.54 | -153.26 |
| Change in Deposit | 62.78 | -281.80 | -1872.83 | 1678.29 |
| Other Changes | -1321.66 | -4013.84 | -3605.45 | 1098.10 |
| Working Capital Change | -1048.03 | -545.16 | -1209.06 | -192.52 |
| Cash Generated From Operations | 631.72 | 1478.01 | 2108.61 | 619.45 |
| Tax | -437.29 | -505.46 | -553.18 | -100.30 |
| Cash Flow From Operations | 194.43 | 972.55 | 1555.43 | 519.15 |
| Purchase of PPE | -641.39 | -575.76 | -870.68 | -252.33 |
| Sale of PPE | 147.30 | 47.56 | 61.58 | 6.34 |
| Purchase of Investment | 0.00 | 0.00 | -3500.00 | 0.00 |
| Sale of investments | 0.00 | 0.00 | 303.37 | 500.97 |
| Others | -805.37 | -3024.68 | -3079.18 | 1098.10 |
| Cash flow from Investment | -1299.46 | -3552.88 | -6085.91 | 1353.08 |
| Proceeds from Borrowing | 4125.66 | 2251.79 | 5818.48 | 228.10 |
| Repayment of Borrowing | 1794.71 | 436.80 | 4169.99 | 1962.92 |
| Dividend | -477.19 | 0.00 | 0.00 | 0.00 |
| Proceeds from Equity | 0.00 | 1387.39 | 3540.09 | 0.00 |
| Others From Financing | -381.50 | -616.53 | -737.53 | -270.04 |
| Cash Flow from Financing | 5061.68 | 3459.45 | 12791.03 | 1920.98 |
| Net Cash Generated | 367.23 | 5.52 | -79.43 | -132.63 |
| Cash at the Start | 1531.33 | 1912.15 | 1867.16 | 1928.30 |
| Cash at the End | 1912.15 | 1867.16 | 1928.30 | 1864.99 |
Data not found
Shareholding Pattern
Ravneet Kaur
0.01%
PVAB Asia Elect
2.52%
PVAB Global Elect
3.87%
PVAB Global Fund I
4.18%
PVAB Eastbound Elect
4.06%
Rihim Developers LLP
0.01%
PVAB Eastbound Fund I
2.33%
Rihim Buildcon Pvt. Ltd.
0.01%
Naad Financial Services Pvt. Ltd.
0.01%
Punita Sharma
1.85%
Gurmit Singh Chugh
4.82%
Evercure Holdings Pte. Ltd.
59.93%
Medicore Holdings Pte. Ltd.
0.83%
Public – Individuals & Institutions (combined)
15.57%
Peer Ratio
| Particulars (cr) | Revenue (FY2025) | EPS (FY2025) | Mcap (08.10.25) | P/E (08.10.25) |
|---|---|---|---|---|
| Poly Medicure Limited | 16698.32 | 34.13 | 1911.00 | 56.02x |
| Laxmi Dental Limited | 2391.07 | 6.07 | 326.40 | 53.95x |
Events
Name
Details
2023
Change of Name – Integris Medtech Limited
The company formally changed its name to “Integris Medtech Limited”.
Name Approval – “Integris Medtech Limited”
The Registrar of Companies approved the new name “Integris Medtech Limited”.
2017
Conversion from Private to Public
The company was converted into a public limited company.
Change of Name – Onepoint One Solutions Limited
The company’s name was changed from “Integris Medtech Limited” to “Onepoint One Solutions Limited”.
2013
Incorporation of Integris Medtech Limited
The company was incorporated as “Integris Medtech Limited”.
Promoters or Management
| Name | Designation | Experience | Social Profile |
|---|---|---|---|
| Evercure Holdings Pte. Ltd. | Promoter | 0 | |
| Medicore Holdings Pte. Ltd. | Promoter | 0 | |
| Gurmit Singh Chugh | Promoter (Also Non-Executive Director in some committees) | 0 | |
| Punita Sharma | Promoter | 0 |
Ready to Build Wealth with Unlisted Stocks?
We give you the data, insights, and access—you make the profit.
Scan to download
Frequently Asked questions
Everything you need to know before you start investing in unlisted shares.
- 1. Reliance Retail
- 2. HDFC Securities
- 3. NSE (National Stock Exchange)
- 4. Paytm Money
- 5. Tata Technologies (Availability may vary—verify before investing.)
